Ignite Creation Date:
2025-12-24 @ 11:24 PM
Ignite Modification Date:
2026-01-03 @ 7:16 AM
Study NCT ID:
NCT03272256
Status:
COMPLETED
Last Update Posted:
2020-10-19
First Post:
2017-08-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Study of IM156 in Patients With Advanced Solid Tumor and Lymphoma
Sponsor:
ImmunoMet Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-09
Start Date Type:
ACTUAL
Primary Completion Date:
2019-12-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-07-28
Completion Date Type:
ACTUAL
First Submit Date:
2017-08-29
First Submit QC Date:
None
Study First Post Date:
2017-09-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-15
Last Update Post Date:
2020-10-19
Last Update Post Date Type:
ACTUAL